RLMD

Relmada Therapeutics, Inc.NASDAQHealthcare

$6.99-1.55%ClosedMarket Cap: $512.6M

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-20	Mizuho	—	Outperform	—
2026-01-23	Leerink Partners	—	Outperform	—
2025-11-19	Mizuho	—	Outperform	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$-0.92	$32.5M	2
Sun Dec 31	$-0.91	$19.0M	3
Mon Dec 31	$-0.61	$88.4M	1
Tue Dec 31	$-0.39	$144.5M	1